drugset / Trial / NCT00881244
Study of AS1411 in Advanced Solid Tumours
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A Phase I open label study of AS1411 in advanced solid tumours. Objectives include determining the MTD and DLT of AS1411, to determine the PK profile of AS1411 and to obtain preliminary evidence of clinical and biological responses to AS1411 therapy.
Timeline
- Start
- 2003-09
- Primary completion
- 2006-06
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AS1411 | Aptamer | — | Intravenous |